An international team of researchers specializing in human challenge studies has initiated a $57 million project to develop advanced vaccines that can block coronaviruses and prevent infections.
The consortium, consisting of more than a dozen scientific teams and organizations, is led by Imperial College London and co-funded by the European Union's Horizon Europe Programme and CEPI, the Coalition for Epidemic Preparedness Innovations.
Read More
